Literature DB >> 2237726

The justification for surgical treatment of metastatic melanoma of the gastrointestinal tract.

M H Khadra1, J F Thompson, G W Milton, W H McCarthy.   

Abstract

Fifty-six patients with symptomatic metastatic melanoma of the gastrointestinal tract (GIT) treated surgically at the Sydney Melanoma Unit between 1974 and 1989 were reviewed. The majority of these patients presented with abdominal pain or symptoms of anemia. The small intestine was the site of metastasis in more than 80 per cent. The mean over-all survival time was 11.7 months (range of one to 60 months) after surgical treatment of a first metastasis to the GIT and 3.6 months (range of zero to 12 months) postoperatively for a second GIT metastasis. Forty-four of the patients reported complete relief of their symptoms postoperatively. The results suggest that an aggressive approach to symptomatic GIT metastases from malignant melanoma is justified both to relieve distressing symptoms and to prolong life.

Entities:  

Mesh:

Year:  1990        PMID: 2237726

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  Metastatic malignant melanoma presenting as malabsorption.

Authors:  C Baliellas; X Pagerols; N Curcó; M García-Font; M Forné; P Vives
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

2.  Jejuno-jejunal invagination due to intestinal melanoma.

Authors:  Giuseppe Resta; Gabriele Anania; Federico Messina; Damiano de Tullio; Gloria Ferrocci; Federico Zanzi; Davide Pellegrini; Rocco Stano; Giorgio Cavallesco; Gianfranco Azzena; Savino Occhionorelli
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

3.  Malignant melanoma with mesenteric metastasis causing an intrapelvic abscess: report of a case.

Authors:  T Hirota; M Kaneda; M Iwasa; H Tamaki; K Tsuneoka; S Tagawa
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

4.  Bleeding per rectum in a patient with an amputated finger.

Authors:  Aijaz Hakeem; Hakim Shafi; Shubana Rasool; Muneer Ahmad
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.